Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Mehra

Showing results (161-170 of 347) with videos related to

Pageof 35
Sort By:
Medical Oncology (Northwood, London, England)|February 4, 2019
Metastatic castration resistant prostate cancer with squamous cell, small cell, and sarcomatoid elements-a clinicopathologic and genomic sequencing-based discussionSteven C Weindorf, Alexander S Taylor, Chandan Kumar-Sinha, et al.
Cancer Research|January 4, 2008
Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancerBeth E Helgeson, Scott A Tomlins, Nameeta Shah, et al.
Cancer Research|April 23, 2009
Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancerRou Wang, David S Morris, Scott A Tomlins, et al.
Neurourology and Urodynamics|May 1, 2023
Destroyed bladders: Characterization of progressive inflammatory cystitisAnna Faris, Giulia I Lane, Rohit Mehra, et al.
The American Journal of Surgical Pathology|March 15, 2016
Renal Cell Carcinoma Occurring in Patients With Prior Neuroblastoma: A Heterogenous Group of NeoplasmsSara M Falzarano, Jesse K McKenney, Rodolfo Montironi, et al.
Cancer Research|April 6, 2006
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancerScott A Tomlins, Rohit Mehra, Daniel R Rhodes, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 15, 2020
PAX8 expression and TERT promoter mutations in the nested variant of urothelial carcinoma: a clinicopathologic study with immunohistochemical and molecular correlatesAlexander S Taylor, Jesse K McKenney, Adeboye O Osunkoya, et al.
Neoplasia (New York, N.Y.)|February 20, 2008
Role of the TMPRSS2-ERG gene fusion in prostate cancerScott A Tomlins, Bharathi Laxman, Sooryanarayana Varambally, et al.
Medical Oncology (Northwood, London, England)|October 7, 2018
Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancerRohit Mehra, Simpa S Salami, Robert Lonigro, et al.
Genome Research|August 9, 2015
The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencingMarcin Cieslik, Rashmi Chugh, Yi-Mi Wu, et al.
Pageof 35

Showing results (161-170 of 347) with videos related to

Sort By:
Pageof 35
Medical Oncology (Northwood, London, England)|February 4, 2019
Metastatic castration resistant prostate cancer with squamous cell, small cell, and sarcomatoid elements-a clinicopathologic and genomic sequencing-based discussionSteven C Weindorf, Alexander S Taylor, Chandan Kumar-Sinha, et al.
Cancer Research|January 4, 2008
Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancerBeth E Helgeson, Scott A Tomlins, Nameeta Shah, et al.
Cancer Research|April 23, 2009
Development of a multiplex quantitative PCR signature to predict progression in non-muscle-invasive bladder cancerRou Wang, David S Morris, Scott A Tomlins, et al.
Neurourology and Urodynamics|May 1, 2023
Destroyed bladders: Characterization of progressive inflammatory cystitisAnna Faris, Giulia I Lane, Rohit Mehra, et al.
The American Journal of Surgical Pathology|March 15, 2016
Renal Cell Carcinoma Occurring in Patients With Prior Neuroblastoma: A Heterogenous Group of NeoplasmsSara M Falzarano, Jesse K McKenney, Rodolfo Montironi, et al.
Cancer Research|April 6, 2006
TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancerScott A Tomlins, Rohit Mehra, Daniel R Rhodes, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 15, 2020
PAX8 expression and TERT promoter mutations in the nested variant of urothelial carcinoma: a clinicopathologic study with immunohistochemical and molecular correlatesAlexander S Taylor, Jesse K McKenney, Adeboye O Osunkoya, et al.
Neoplasia (New York, N.Y.)|February 20, 2008
Role of the TMPRSS2-ERG gene fusion in prostate cancerScott A Tomlins, Bharathi Laxman, Sooryanarayana Varambally, et al.
Medical Oncology (Northwood, London, England)|October 7, 2018
Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancerRohit Mehra, Simpa S Salami, Robert Lonigro, et al.
Genome Research|August 9, 2015
The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencingMarcin Cieslik, Rashmi Chugh, Yi-Mi Wu, et al.
Pageof 35